Skip to main content

Featured

Holy Week Tensions Rise as Israel Blocks Cardinal from Entering Sacred Jerusalem Site

  Cardinal Pierbattista Pizzaballa, the Latin patriarch of Jerusalem, holds a prayer service to mark Palm Sunday, following the cancellation of the traditional Palm Sunday procession from the Mount of Olives, amid restrictions on gathering in large groups, in Jerusalem, March 29, 2026. Israeli police prevented Cardinal Pierbattista Pizzaballa, the Latin Patriarch of Jerusalem, from entering the Church of the Holy Sepulchre on Palm Sunday, prompting widespread criticism from Christian leaders and governments worldwide. Authorities cited security concerns linked to the ongoing U.S.-Israeli war with Iran, noting that all holy sites in Jerusalem’s Old City had been temporarily closed due to the threat of missile strikes. The Latin Patriarchate condemned the move as an unprecedented disruption of centuries‑old tradition, marking the first time church leaders were unable to celebrate Palm Sunday Mass at the historic site. Israeli Prime Minister Benjamin Netanyahu later stated that the ...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment